HCP, Inc. (HCP) Shares Bought by Eliot Finkel Investment Counsel LLC

Eliot Finkel Investment Counsel LLC grew its stake in shares of HCP, Inc. (NYSE:HCP) by 5.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 91,165 shares of the real estate investment trust’s stock after purchasing an additional 4,785 shares during the period. HCP makes up about 1.8% of Eliot Finkel Investment Counsel LLC’s holdings, making the stock its 28th largest position. Eliot Finkel Investment Counsel LLC’s holdings in HCP were worth $2,537,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of HCP. FMR LLC boosted its position in shares of HCP by 2.4% in the 1st quarter. FMR LLC now owns 214,161 shares of the real estate investment trust’s stock worth $6,699,000 after buying an additional 5,007 shares in the last quarter. Bank of Montreal Can boosted its position in shares of HCP by 59.6% in the 2nd quarter. Bank of Montreal Can now owns 595,192 shares of the real estate investment trust’s stock worth $19,022,000 after buying an additional 222,258 shares in the last quarter. Eqis Capital Management Inc. boosted its position in shares of HCP by 7.7% in the 2nd quarter. Eqis Capital Management Inc. now owns 14,048 shares of the real estate investment trust’s stock worth $449,000 after buying an additional 1,009 shares in the last quarter. LS Investment Advisors LLC boosted its position in shares of HCP by 5.4% in the 2nd quarter. LS Investment Advisors LLC now owns 27,975 shares of the real estate investment trust’s stock worth $894,000 after buying an additional 1,439 shares in the last quarter. Finally, Louisiana State Employees Retirement System boosted its position in shares of HCP by 1.0% in the 2nd quarter. Louisiana State Employees Retirement System now owns 29,100 shares of the real estate investment trust’s stock worth $930,000 after buying an additional 300 shares in the last quarter. Institutional investors own 91.09% of the company’s stock.

HCP, Inc. (NYSE HCP) traded down $0.07 during midday trading on Friday, hitting $26.84. 4,430,400 shares of the stock were exchanged, compared to its average volume of 3,720,831. HCP, Inc. has a one year low of $25.08 and a one year high of $33.67. The company has a debt-to-equity ratio of 1.17, a quick ratio of 0.61 and a current ratio of 0.61. The firm has a market cap of $12,580.00, a P/E ratio of 13.06, a P/E/G ratio of 2.87 and a beta of 0.31.

HCP (NYSE:HCP) last posted its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.48 EPS for the quarter, beating the Zacks’ consensus estimate of $0.46 by $0.02. HCP had a net margin of 27.31% and a return on equity of 8.85%. The company had revenue of $454.00 million during the quarter, compared to the consensus estimate of $440.60 million. During the same quarter in the prior year, the company posted $0.72 EPS. The company’s quarterly revenue was down 14.4% compared to the same quarter last year. analysts expect that HCP, Inc. will post 1.94 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 21st. Stockholders of record on Monday, November 6th will be paid a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.51%. The ex-dividend date is Friday, November 3rd. HCP’s dividend payout ratio is currently 264.29%.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.com-unik.info/2017/11/17/hcp-inc-hcp-shares-bought-by-eliot-finkel-investment-counsel-llc.html.

Several research firms recently commented on HCP. KeyCorp reiterated a “hold” rating on shares of HCP in a research report on Sunday, September 17th. BMO Capital Markets reiterated a “hold” rating and issued a $28.00 price objective on shares of HCP in a research report on Wednesday, October 18th. BidaskClub lowered shares of HCP from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Mizuho raised shares of HCP from a “neutral” rating to a “buy” rating and set a $32.00 target price for the company in a research note on Thursday, November 2nd. Finally, Zacks Investment Research downgraded shares of HCP from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Three analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $30.91.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Institutional Ownership by Quarter for HCP (NYSE:HCP)

What are top analysts saying about HCP Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HCP Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit